Implementing Digital Biomarkers in Clinical Trials: Early Success and Best Practices
Webinar Date/Time: Tue, Mar 26, 2024 11:00 AM EDT
Considering digital measurements in your trials? Join us for an insightful webinar as we explore early success, best practices, and game-changing impacts of digital biomarkers used for the measurement of neurological disease progression and advancement of clinical research.
Register Free: https://www.appliedclinicaltrialsonline.com/act/digital-biomarkers
Event overview
Digital biomarkers (dBMs) are revolutionizing clinical trials by enabling smaller and faster proof-of-concept studies. Join us to explore the benefits of dBMs for the measurement of neurological disease progression and advancement of clinical research. With experience in dBMs in over 30+ studies, we will provide key takeaways and a deeper understanding of incorporating digital biomarkers into trials.
Key Learning Objectives
- Understand how digital biomarkers are incorporated into trials, enabling faster proof-of-concept studies
- Explore the benefits of digital biomarkers in measuring neurological disease progression
- Gain practical insights on incorporating digital biomarkers into trials
Who Should Attend
- Biotech researchers and leaders who are interested in incorporating digital measures in trials.
- Leaders of Clinical Development, Clinical Trials, Clinical Research in neurological and movement disorders.
- Leaders of Digital Sciences, Digital Measurements, Data Science, Digital Health.
Speakers:
Anya Gupta
Sr. Business Product Manager
Roche
Anya leads product strategy and development at Roche for its Digital Biomarkers in Clinical Trials program. Prior to Roche, Anya worked at Kaiser Permanente and IBM, where her role focused on the commercialization of diagnostics, biomarker, and health data products. Anya has an MBA from MIT Sloan and a BA in Economics from the University of Virginia.
Florian Lipsmeier, PhD
Digital Biomarker Data Insights Lead
Roche
Dr Florian Lipsmeier is the Digital Biomarker Data Insights subchapter lead at Roche. He trained as a Bioinformatician and Biomathematician and holds a PhD from Bielefeld University, Germany.
He started his career at Roche Pharma pRED Innovation Center Munich in 2010 as a data scientist supporting antibody development, before moving to Basel in 2016 to focus his work solely on digital biomarkers—first for Roche Pharma pRED and now for Roche Diagnostics RIS. Dr Lipsmeier has deep experience developing and leading teams for signal processing and data science on Digital Health Technology derived sensor data. He is a co-author of more than 30 patents and manuscripts around digital biomarker and more than 90 conference posters, and is the co-founder of the EBI Digital Biomarker workshop series. Dr Lipsmeier is a recognized expert on digital biomarker science.
Register Free: https://www.appliedclinicaltrialsonline.com/act/digital-biomarkers
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
